Literature DB >> 32524998

Liver fibrogenesis: un update on established and emerging basic concepts.

Erica Novo1, Claudia Bocca1, Beatrice Foglia1, Francesca Protopapa1, Marina Maggiora1, Maurizio Parola2, Stefania Cannito1.   

Abstract

Liver fibrogenesis is defined as a dynamic and highly integrated process occurring during chronic injury to liver parenchyma that can result in excess deposition of extracellular matrix (ECM) components (i.e., liver fibrosis). Liver fibrogenesis, together with chronic inflammatory response, is then primarily involved in the progression of chronic liver diseases (CLD) irrespective of the specific etiology. In the present review we will first offer a synthetic and updated overview of major basic concepts in relation to the role of myofibroblasts (MFs), macrophages and other hepatic cell populations involved in CLD to then offer an overview of established and emerging issues and mechanisms that have been proposed to favor and/or promote CLD progression. A special focus will be dedicated to selected issues that include emerging features in the field of cholangiopathies, the emerging role of genetic and epigenetic factors as well as of hypoxia, hypoxia-inducible factors (HIFs) and related mediators.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholangiopaties; Genetic factors; Hypoxia-inducible factors; Liver fibrogenesis; Macrophages; Myofibroblasts

Year:  2020        PMID: 32524998     DOI: 10.1016/j.abb.2020.108445

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Application and Prospect of Platelet Multi-Omics Technology in Study of Blood Stasis Syndrome.

Authors:  Ying Li; Ming-Qian Sun; Lei Li; Ye-Hao Zhang; Lan Miao; Jian-Xun Liu
Journal:  Chin J Integr Med       Date:  2021-12-20       Impact factor: 1.978

Review 2.  The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics.

Authors:  Aziz Eftekhari; Allahveirdy Arjmand; Ayyub Asheghvatan; Helena Švajdlenková; Ondrej Šauša; Huseyn Abiyev; Elham Ahmadian; Oleh Smutok; Rovshan Khalilov; Taras Kavetskyy; Magali Cucchiarini
Journal:  Front Chem       Date:  2021-05-14       Impact factor: 5.221

Review 3.  Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment.

Authors:  Claire E McQuitty; Roger Williams; Shilpa Chokshi; Luca Urbani
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

Review 4.  Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis.

Authors:  Rasmus Hvidbjerg Gantzel; Mikkel Breinholt Kjær; Tea Lund Laursen; Konstantin Kazankov; Jacob George; Holger Jon Møller; Henning Grønbæk
Journal:  Front Med (Lausanne)       Date:  2021-01-08

Review 5.  Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis.

Authors:  Claudia Bocca; Francesca Protopapa; Beatrice Foglia; Marina Maggiora; Stefania Cannito; Maurizio Parola; Erica Novo
Journal:  Antioxidants (Basel)       Date:  2022-06-28

6.  Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity.

Authors:  Ivan Rusyn; Xabier Arzuaga; Russell C Cattley; J Christopher Corton; Stephen S Ferguson; Patricio Godoy; Kathryn Z Guyton; Neil Kaplowitz; Salman R Khetani; Ruth A Roberts; Robert A Roth; Martyn T Smith
Journal:  Hepatology       Date:  2021-07-13       Impact factor: 17.298

Review 7.  Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.

Authors:  Pietro Torre; Benedetta Maria Motta; Roberta Sciorio; Mario Masarone; Marcello Persico
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.